PCM
LLY icon

Princeton Capital Management’s Eli Lilly LLY Stock Holding History

Princeton Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.2M Buy
16,519
+312
+2% +$316K 4.14% 7
2025
Q4 		$17.4M Sell
16,207
-143
-0.9% -$137K 4.49% 6
2025
Q3 		$12.5M Buy
16,350
+1,202
+8% +$894K 3.35% 7
2025
Q2 		$11.8M Sell
15,148
-263
-2% -$204K 3.51% 7
2025
Q1 		$12.7M Buy
15,411
+9
+0.1% +$7.49K 4.48% 6
2024
Q4 		$11.9M Buy
15,402
+496
+3% +$411K 3.68% 7
2024
Q3 		$13.2M Buy
14,906
+917
+7% +$824K 4.16% 6
2024
Q2 		$12.7M Buy
13,989
+232
+2% +$186K 4.13% 6
2024
Q1 		$10.7M Sell
13,757
-277
-2% -$197K 3.86% 6
2023
Q4 		$8.18M Buy
14,034
+183
+1% +$107K 3.3% 7
2023
Q3 		$7.44M Buy
13,851
+3,520
+34% +$1.81M 3.43% 7
2023
Q2 		$4.84M Sell
10,331
-56
-0.5% -$23.5K 2.01% 15
2023
Q1 		$3.57M Sell
10,387
-744
-7% -$251K 1.53% 21
2022
Q4 		$4.07M Sell
11,131
-617
-5% -$219K 1.81% 19
2022
Q3 		$3.8M Buy
11,748
+1,789
+18% +$567K 1.66% 18
2022
Q2 		$3.23M Buy
9,959
+6,743
+210% +$2.02M 1.25% 25
2022
Q1 		$921K Buy
3,216
+79
+3% +$20.3K 0.29% 59
2021
Q4 		$867K Buy
3,137
+24
+0.8% +$6.08K 0.25% 63
2021
Q3 		$719K Buy
3,113
+54
+2% +$13.3K 0.23% 65
2021
Q2 		$702K Buy
3,059
+460
+18% +$92.4K 0.22% 64
2021
Q1 		$486K Buy
2,599
+484
+23% +$94.7K 0.16% 70
2020
Q4 		$357K Hold
2,115
– – 0.13% 75
2020
Q3 		$313K Sell
2,115
-79
-4% -$12.2K 0.13% 73
2020
Q2 		$360K Buy
2,194
+529
+32% +$81.2K 0.16% 72
2020
Q1 		$261K Buy
1,665
+228
+16% +$31.3K 0.14% 74
2019
Q4 		$210K Buy
1,437
+370
+35% +$42.9K 0.09% 91
2019
Q3 		$119K Sell
1,067
-18
-2% -$2K 0.06% 109
2019
Q2 		$120K Hold
1,085
– – 0.06% 110
2019
Q1 		$141K Hold
1,085
– – 0.07% 107
2018
Q4 		$126K Hold
1,085
– – 0.07% 106
2018
Q3 		$116K Hold
1,085
– – 0.05% 127
2018
Q2 		$93K Hold
1,085
– – 0.04% 138
2018
Q1 		$84K Buy
+1,085
New +$87.3K 0.04% 139
2016
Q4 		$981K Sell
13,344
-3,481
-21% -$259K 1.42% 26
2016
Q3 		$1.35M Sell
16,825
-3,830
-19% -$307K 1.67% 17
2016
Q2 		$1.63M Buy
20,655
+750
+4% +$56.5K 1.86% 14
2016
Q1 		$1.43M Buy
19,905
+1,215
+7% +$91.9K 1.62% 24
2015
Q4 		$1.57M Buy
18,690
+10
+0.1% +$830 1.77% 16
2015
Q3 		$1.56M Buy
18,680
+15,925
+578% +$1.34M 1.77% 8
2015
Q2 		$230K Hold
2,755
– – 0.23% 78
2015
Q1 		$200K Sell
2,755
-495
-15% -$35.2K 0.2% 84
2014
Q4 		$224K Hold
3,250
– – 0.22% 80
2014
Q3 		$211K Hold
3,250
– – 0.19% 78
2014
Q2 		$202K Buy
+3,250
New +$194K 0.17% 83

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Princeton Capital Management's LLY Position: Q1 2026 in Review

Princeton Capital Management increased its Eli Lilly (LLY) stake by 1.9% in Q1 2026, buying an estimated $316K and bringing the position to 16,519 shares worth $15.2M. The position accounts for 4.14% of the portfolio, ranked #7.

Princeton Capital Management first reported a position in LLY in Q2 2014 and has held it in 44 quarters since. The position peaked at $17.4M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Princeton Capital Management held 16,519 shares of Eli Lilly worth $15.2M as of Q1 2026.
  • Princeton Capital Management bought 312 Eli Lilly shares in Q1 2026, an estimated $316K.
  • Eli Lilly made up 4.14% of Princeton Capital Management's portfolio in Q1 2026, its #7 holding.
  • Princeton Capital Management first reported a position in Eli Lilly in Q2 2014 and has held it in 44 quarters since.
  • Princeton Capital Management's Eli Lilly position peaked at $17.4M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Princeton Capital Management's 13F filing for Q1 2026, filed 8 May 2026.